Edition:
United States

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

57.00USD
25 Sep 2017
Change (% chg)

$-0.43 (-0.75%)
Prev Close
$57.43
Open
$57.51
Day's High
$57.51
Day's Low
$56.58
Volume
65,824
Avg. Vol
131,754
52-wk High
$59.87
52-wk Low
$30.69

Chart for

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximatel... (more)

Overall

Beta: 1.52
Market Cap(Mil.): $3,334.36
Shares Outstanding(Mil.): 58.06
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.44 16.08
EPS (TTM): -- -- --
ROI: -- 13.78 14.60
ROE: -- 16.62 14.03

BRIEF-Insulet Corp appoints two board of directors

* Insulet Corporation appoints Michael R. Minogue and James C. Mullen to board of directors Source text for Eikon: Further company coverage:

Aug 10 2017

BRIEF-Insulet reports Q2 loss per share $0.13

* Q2 revenue $109.8 million versus I/B/E/S view $106.2 million

Aug 03 2017

BRIEF-Ypsomed to separate from Insulet

* TO SEPARATE FROM INSULET AND EXTEND ITS PORTFOLIO WITH AN OWN PATCH PUMP IN MID-TERM

Jul 21 2017

BRIEF-Insulet to assume distribution and commercial support for its Omnipod system in Europe

* Insulet to assume distribution and commercial support for its Omnipod system in Europe

Jul 20 2017

BRIEF-Insulet presents positive omnipod horizon hybrid closed-loop study results in children

* Insulet presents positive omnipod® horizon™ hybrid closed-loop study results in children

Jun 12 2017

Competitors

Earnings vs. Estimates